Related references
Note: Only part of the references are listed.Interaction Potential of Etravirine with Drug Transporters Assessed In Vitro
Nadine Cecile Luise Zembruski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Transporter-Mediated Drug-Drug Interactions
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Utility of In Vitro Data in Making Accurate Predictions of Human P-Glycoprotein-Mediated Drug-Drug Interactions: A Case Study for AZD5672
Robert Elsby et al.
DRUG METABOLISM AND DISPOSITION (2011)
Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro
Nadine Cecile Luise Zembruski et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC50 and [I2]/IC50, That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies
Jack A. Cook et al.
MOLECULAR PHARMACEUTICS (2010)
Transporters in drug development: advancing on the Critical Path
Shiew-Mei Huang et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Drug-Drug Interactions Mediated Through P-Glycoprotein: Clinical Relevance and In Vitro-In Vivo Correlation Using Digoxin as a Probe Drug
K. S. Fenner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
A regulatory viewpoint on transporter-based drug interactions
L. Zhang et al.
XENOBIOTICA (2008)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Share Paper
